What were the findings of Chaudhary et al.'s systematic review and meta-analysis regarding the use of dual antiplatelet therapy (DAPT) and vitamin K antagonists (VKA) for treating patients with nonvalvular atrial fibrillation?
Chaudhary et al.'s systematic review and meta-analysis showed that DAPT and VKA were associated with a significantly lower risk of stroke, stent thrombosis, and all-cause mortality, but the risk of major bleeding was significantly higher in the DAPT and VKA group.